Topic 2: Fatigue Flashcards
What is MS (multiple sclerosis)
An inflammatory disease of the central nervous system that results in myelin destruction and axonal degeneration in the brain and spinal cord.
The relapsing-remitting MS subtype is characterized by ..
clearly defined episodes of neurological dysfunction (relapse) separated by periods of relative clinical stability (remissions).
The majority of untreated cases of relapsing-remitting MS evolve into a …
secondary-progressive phase
A secondary progressive phase in MS is characterized by …
a gradual, insidious deterioration, usually in the form of paraparesis, hemiparesis, or dementia.
The primary-progressive subtype of MS is characterized by …
a slow deterioration in neurologic function from onset, without distinct relapses
What is the effect of therapies for the management of MS?
these therapies can decrease the frequency of clinical relapses and new radiological lesion formation. However, non of these therapies reverse preexistig tissue damage of control chronic symptoms such as fatigue, that are common to all MS subtypes.
What is considered to be one of the main causes of impaired quality of life among MS patients?
Fatigue, independent of depression or disability.
Fatigue in MS remains poorly understood and often underemphasized for several reasons.
- fatigue is a subjective symptom without a unified definition
- Ambiguity arises because no gold standard exists by which to measure fatigue
- whereas questionnaires can be helpful to rate the level of fatigue, most do not include questions to qualify or define the fatigue.
- fatigue in MS patients may be multifactorial
The most commonly proposed primary mechanisms of fatigue in MS involve the immune system or sequelae from central nervous system damage. Specific causes are thought to include:
- proinflammatory cytokines
- endocrine influences
- axonal loss
- altered patterns of cerebral activation
What is known about cytokine influences in fatigue in MS
Cytokines implicated in the disease are thought to be strong mediators of fatigue. interferon-gamma and TNF-alpha are the most studied. These cytokines are significantly increased in fatigued MS patients compared to non-fatigued patients. Both cytokines are relatively nonspecific and may be elevated in a variety of inflammatory conditions
What is known about endocrine influences in fatigue in MS?
The HPA-axis and the hormone DHEA are most studied. Both low cortisol and low DHEA levels have been implicated in CFS, and low DHEA levels are found in patients with lupus and rheuma. Lower levels of DHEA have been demonstrated in MS patients with sustained fatigue than their non-fatigued counterparts.
What is evidence for possible hormonal influence in fatigue in MS?
the fact that many MS patients report increased energy while taking corticosteroids as treatment for their neurologic symptoms further supports a possible hormonal influence.
Why are steroids not advocated as treatment for fatigue in MS?
because of the chronic nature of fatigue and risks of long-term steroid use
PET demonstrates decreased regional glucose metabolism in various brain structures of fatigued MS patients, which structures?
decreased regional glucose metabolism in the frontal cortex and basal ganglia
Fatigue in MS also can arise from associated conditions or accumulation of disease burden. Specific causes to consider include …
- sleep disorders
- depression
- disability status
- MS subtype
- iatrogenicity
Which sleep disorders may affect MS patients?
- RLS
- periodic limb movement disorder
- chronic insomnia
- circadian rhythm disturbances
- sleep disordered breathing
What is the prevalence of RLS in MS patients?
The prevalence of RLS among MS patients is approximately 3-5 times that of the general population
Risk for chronic insomnia may arise secondary to ..
- pain
- spasticity
- depression
- anxiety
- nocturia
- medication effects
- RLS
- periodic limb movement disorder
What is the prevalence of depression in MS patients?
50%
In which MS subtype is fatigue most severe?
Fatigue appears to be most severe in patients with progressive subtypes of MS, but this observation may in part be confounded by disability levels
The Chalder Fatigue Scale was created for ..
CFS patients
The Chalder Fatigue Scale quantifies fatigue intensity in terms of ..
physical and mental domains
Advantages of the Chalder Fatigue Scalre include ..
its ease of use and brevity. Although it has demonstrated good internal consistency in patients with CFS, MS-specific assessments of validity and consistency for this instruments are lacking.
Krupp’s Fatigue Severity Scale is designed ..
to identify common features of fatigue in both MS and lupus patients, the FSS assesses the impact of fatigue on multiple outcomes, with a physical focus.
the FSS can differentiate between …
subgroups of MS, CFS, and primary depression